STOCK TITAN

Insider at NRIX (NASDAQ: NRIX) files Rule 144 to sell 14,261 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of NRIX has filed a Rule 144 notice to sell 14,261 common shares, with an aggregate market value of $240,297.85, through Morgan Stanley Smith Barney on the NASDAQ, with an approximate sale date of 02/09/2026.

The shares were acquired as restricted stock units from the issuer on 05/02/2022. The filing also notes prior sales under a Rule 10b5-1 plan, including 3,760 shares sold on 01/20/2026 for $69,273.11 and 37,600 shares sold on 11/24/2025 for $641,697.02. Shares outstanding were 102,843,012 at the time referenced.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Nurix Therapeutics, Inc.

NASDAQ:NRIX

NRIX Rankings

NRIX Latest News

NRIX Latest SEC Filings

NRIX Stock Data

1.62B
99.82M
1.43%
115.02%
16.76%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRISBANE